Search the Newsreel

Wall Street Analysts Believe Generac Holdings (GNRC) Could Rally 31.51%: Here's is How to Trade

Generac Holdings (GNRC) closed the last trading session at $216.66, gaining 0.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target …

Allogene Therapeutics (ALLO) Income Statement & Earnings

UBS Adjusts PT on Cogent Communications to $11 From $17, Maintains Neutral Rating

UBS has lowered its price target for Cogent Communications (CCOI) to $11 from $17, while maintaining a Neutral rating on the stock. This adjustment reflects a revised outlook for the integrated telecommunications services provider. The company's stock is currently trading at $10.90, down -49.44% …

NexGen Energy begins construction on its first uranium mine in Saskatchewan

NexGen Energy Ltd. has started construction on its $2.2 billion Rook I uranium mine project in northern Saskatchewan. The project, located on the southern end of the Athabasca Basin, is expected to take four years to build and will eventually produce 30 million pounds …

Implied Volatility Surging for Banco Bilbao Stock Options

Implied volatility for Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) stock options, particularly the Sept. 18, 2026 $25.00 Call, is surging, indicating that the market anticipates a significant price movement. Despite this, analysts currently rate Banco Bilbao as a Zacks Rank #4 (Sell), suggesting a …

Genting Singapore (SGX:G13) Stock Rally Meets Shrinking Earnings Power

Ultragenyx (RARE): RTW Investments and Roderick Wong report 7.9% stake

RTW Investments, LP and Roderick Wong, M.D. have reported a beneficial ownership of 7.9% in Ultragenyx Pharmaceutical Inc., totaling 7,796,895 shares. This disclosure, made via a Schedule 13G filing, indicates shared voting and dispositive power over these shares, which are held by funds advised …

Vistagen reports Q1 FY2027: $1.48M revenue, $13.0M net loss, $31.7M cash at June 30, 2026

Vistagen announced its Q1 FY2027 results, reporting $1.476 million in revenue and a net loss of $13.03 million. The company ended the quarter with $31.7 million in cash, expecting these funds to support operations into 2027. Vistagen also highlighted upcoming FDA discussions regarding a …

Form 8K VistaGen Therapeutics Inc For: 14 August By Investing.com

This article announces that VistaGen Therapeutics Inc. has filed a Form 8K on August 14th. The brief news item from Investing.com provides no further details about the content of the filing but notes the stock symbol VTGN.

Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update

Vistagen announced its fiscal year 2027 first-quarter financial results, highlighting progress in its fasedienol program for social anxiety disorder, including plans for FDA engagement regarding a Phase 3 pathway. The company reported a net loss of $13.0 million, reduced R&D and G&A expenses due …

VistaGen Therapeutics GAAP EPS of -$0.30 beats by $0.06, revenue of $1.48M beats by $1.31M

* VistaGen Therapeutics press release [https://seekingalpha.com/pr/20619736-vistagen-reports-fiscal-year-2027-first-quarter-financial-results-and-corporate-update] (VTGN [https://seekingalpha.com/symbol/VTGN]): Q1 GAAP EPS of -$0.30 beats by $0.06. * Revenue of $1.48M (+516.7% Y/Y) beats by $1.31M. * Cash, cash equivalents, and marketable securities were $31.7 million as of June 30, 2026. Based on current operating …

Gentex Corp (NASDAQ:GNTX): A Sustainable Dividend for Quality-Focused Investors

Q3 Earnings Forecast for Neurogene Issued By HC Wainwright

NexGen breaks ground on major uranium mine in northern Sask.

NexGen Energy Ltd. has officially started construction on its $2.2 billion Rook I Project, an underground uranium mine in northern Saskatchewan's Athabasca Basin. This mine is projected to become one of the world's largest new sources of uranium, potentially supplying up to 20% of …

Ocugen, Inc. (NASDAQ:OCGN) Receives Average Rating of "Moderate Buy" from Analysts

Ocugen, Inc. (NASDAQ:OCGN) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $9.50. Insider buying by CFO Treerita Essali Johnson-Greene and increased institutional holdings indicate positive sentiment, though the stock has been under pressure after reporting a …

BBVA stock holds near recent highs as half-year profit sets a new record

BBVA stock is trading near its recent highs after the bank reported a record €6.051 billion net profit for the first half of 2026, an 11% increase year-over-year. The company also raised its return-on-tangible-equity target to 21% for the full year. Despite a consensus …

Amgen (AMGN) Stock Looks Undervalued With A 37% Fair Value Gap

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Amgen stock has delivered strong gains over the past five years, yet the current …

International General Insurance Holdings Ltd. (NASDAQ:IGIC) Looks Interesting, And It's About To Pay A Dividend

International General Insurance Holdings Ltd. (NASDAQ:IGIC) is preparing to pay a dividend of US$0.075 per share, with an ex-dividend date around August 18th. The company boasts a strong dividend profile, paying out only 14% of its after-tax profit and demonstrating rapid earnings growth of …

GD|General Dynamics Corp|Price:392.980|Chg%:-1.230

Evogene chairman to address dissident shareholder issues in Aug 18 earnings call

Evogene Ltd. announced that its Chairman, Nir Nimrodi, will discuss issues with dissident shareholders during the company's quarterly earnings call on August 18, 2026. The computational chemistry company aims to provide clarity on the situation and its potential impact on the company and investors. …

Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation

Evogene (Nasdaq: EVGN) announced that Chairman Nir Nimrodi will participate in the company's upcoming quarterly results Zoom conference call on Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time). Nimrodi will address the current situation involving certain dissident shareholders and …

Amgen (AMGN) Opens New Science And Innovation Center In Hyderabad

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Amgen (NasdaqGS:AMGN) announced the opening of a new Science and Innovation Center in Genome Valley, Hyderabad, expanding its global research and development presence. The Hyderabad center is …

Volkswagen (XTRA:VOW3) Stock Gets Fair Value Trim After Analyst Target Cuts

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Volkswagen sits in the spotlight after analysts trimmed the average price target from €109 to about €105, with individual updated targets clustering around €115 …

General Dynamics Corp (GD) Stock Price Live, Chart & News - TradingKey

This article provides a detailed overview of General Dynamics Corp (GD) stock, including its current price, market capitalization, key financial figures, news, analyst ratings, and technical analysis. It highlights recent performance, forecast earnings, company profile, and major shareholders, presenting a comprehensive financial snapshot for …

IREDA vs Inox Wind: Renewable Energy Stocks Down 7%, Buy The Dip Or Stay Away?

Evogene Chairman Joins Company Results Call on August 18

Henan Jinyuan Sets Board Meeting to Review Interim Results and Consider Dividend

REGENXBIO (NASDAQ:RGNX) Rating Increased to Hold at Zacks Research

Zacks Research has upgraded REGENXBIO (NASDAQ:RGNX) from a "strong sell" to a "hold" rating. This upgrade comes as the biotechnology company exceeded revenue and EPS estimates in its latest quarterly report, though it remains unprofitable. Institutional investors hold a significant portion of the company's …

Legence Corp. Class A Common stock (NASDAQ: LGN) Share Price, LGN Stock News, LGN Share Price & Updates

This page provides an overview of Legence Corp. Class A Common stock (NASDAQ: LGN), including its current share price, recent news, and financial data. It offers details on fundamental metrics, active day range, and 52-week range. The article also lists analyst recommendations and links …

Legence Corp. Class A Common stock Q2 2026 Earnings Call Summary

Legence Corp. reported strong Q2 2026 results with nearly 60% organic revenue growth, primarily driven by the data center and technology market, and achieved a record $5.7 billion backlog. The company raised its full-year 2026 revenue guidance to $4.7-$4.8 billion and is actively pursuing …

Cathay General Bancorp (NASDAQ:CATY) Rating Lowered to "Hold" at Zacks Research

Zacks Research downgraded Cathay General Bancorp (NASDAQ:CATY) from "strong buy" to "hold," aligning with the broader analyst consensus and an average price target of $62.25. The company recently reported quarterly EPS of $1.37, beating estimates, and revenue increased 13.1% year over year. Despite the …

NexGen Energy (ASX:NXG) Drops Sharply as Uranium Stocks Retreat

Die Genmab-Aktie profitiert von angehobener Prognose und robustem Epkinly-Wachstum

Steigerwald Gordon & Koch Inc. Has $1.43 Million Stake in General Mills, Inc. $GIS

Steigerwald Gordon & Koch Inc. significantly reduced its stake in General Mills by 66.1% in the second quarter, selling nearly 80,000 shares but still retaining over 40,000 shares valued at about $1.43 million. Despite analyst caution with a "Reduce" rating, General Mills exceeded Q2 …

Bernstein Adjusts PT on Regeneron Pharmaceuticals to $756 From $753, Maintains Market Perform Rating

Bernstein has increased its price target for Regeneron Pharmaceuticals (REGN) to $756 from $753, while maintaining a "Market Perform" rating on the stock. This adjustment reflects a modest change in the analyst's valuation, indicating a continued neutral stance on the company's stock performance. The …

General Mills, Inc. $GIS Stock Holdings Increased by Handelsbanken Fonder AB

Handelsbanken Fonder AB has increased its stake in General Mills (GIS) by 15.6% in the second quarter, now holding 307,312 shares valued at approximately $10.7 million. This comes as General Mills reported strong quarterly earnings of $0.95 per share, surpassing estimates, and a 1.2% …